Introduction to the special issue of the 3rd International Colloquium on design, branding and marketingJOURNAL OF RETAILING AND CONSUMER SERVICESIF13.12020-07-010PREAI
P2-Quinazolinones and Bis-Macrocycles as New Templates for Next-Generation Hepatitis C Virus NS3/4a Protease Inhibitors: Discovery of MK-2748 and MK-6325CHEMMEDCHEMIF3.42015-03-1021PREAI
Discovery of MK-5172, a Macrocyclic Hepatitis C Virus NS3/4a Protease InhibitorACS MEDICINAL CHEMISTRY LETTERSIF42012-03-02160OA
Discovery of MK-1220: A Macrocyclic Inhibitor of Hepatitis C Virus NS3/4A Protease with Improved Preclinical Plasma ExposureACS MEDICINAL CHEMISTRY LETTERSIF42011-01-1237OAAI
MK-5172: A NOVEL HCV NS3/4A PROTEASE INHIBITOR WITH POTENT ACTIVITY AGAINST KNOWN RESISTANCE MUTANTSJOURNAL OF HEPATOLOGYIF332010-04-012PREAI
Discovery of Vaniprevir (MK-7009), a Macrocyclic Hepatitis C Virus NS3/4a Protease InhibitorJOURNAL OF MEDICINAL CHEMISTRYIF6.82010-02-17157PREAI
MK-7009, a Potent and Selective Inhibitor of Hepatitis C Virus NS3/4A ProteaseANTIMICROBIAL AGENTS AND CHEMOTHERAPYIF4.52010-01-01127OAAI
Bismacrocyclic Inhibitors of Hepatitis C NS3/4a ProteaseANGEWANDTE CHEMIE-INTERNATIONAL EDITIONIF16.92008-11-0552PREAI
Atrial antifibrillatory effects of structurally distinct IKur blockers 3-[(Dimethylamino)methyl]-6-methoxy-2-methyl-4-phenylisoquinolin-1(2H)-one and 2-phenyl-1,1-dipyridin-3-yl-2-pyrrolidin-1-yl-ethanol in dogs with underlying heart failureJOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICSIF3.82008-01-0131PREAI
Design and synthesis of novel isoquinoline-3-nitriles as orally bioavailable Kv1.5 antagonists for the treatment of atrial fibrillationJOURNAL OF MEDICINAL CHEMISTRYIF6.82006-10-27105PREAI